0

Purchase Short-Term Access

Responding to the Rofecoxib Withdrawal Crisis: A New Model for Notifying Patients at Risk and Their Health Care Providers
Anil Jain, MD; Ashish Atreja, MD, MPH; C. Martin Harris, MD, MBA; Meghan Lehmann, PharmD; Jon Burns, BS; James Young, MD
Annals of Internal Medicine 2005;142:182-186. doi:10.7326/0003-4819-142-3-200502010-00008

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)